Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis

被引:50
作者
Briesemeister, Dana [1 ]
Sommermeyer, Daniel [2 ]
Loddenkemper, Christoph [3 ]
Loew, Rainer [4 ]
Uckert, Wolfgang [2 ,5 ]
Blankenstein, Thomas [1 ,2 ]
Kammertoens, Thomas [1 ]
机构
[1] Charite Campus Benjamin Franklin, Inst Immunol, D-12200 Berlin, Germany
[2] Max Delbruck Ctr Mol Med, Berlin, Germany
[3] Charite Campus Benjamin Franklin, Inst Pathol, D-12200 Berlin, Germany
[4] Eufets GmbH, Idar Oberstein, Germany
[5] Humboldt Univ, Inst Biol, Berlin, Germany
关键词
interferon gamma; tumor microenvironment; established tumors; ANTIGEN-LOSS VARIANTS; IFN-GAMMA; T-CELLS; STROMA; TNF; IMMUNOTHERAPY; ANGIOGENESIS; REQUIREMENT; INHIBITION; PERFORIN;
D O I
10.1002/ijc.25350
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
It has been shown that injecting a suspension of IFN-gamma-secreting tumor cells results in their rejection. This effect has been attributed to IFN-gamma preventing tumor stroma formation but not to a direct effect on the cancer cells. However, it is not known, which influence IFN-gamma has on tumors with an established stroma. To address this question, the plasmacytoma cell line J558L was transduced with a vector allowing doxycycline-inducible IFN-gamma gene expression. After the injection of the tumor cells into mice, IFN-gamma was induced at different time points. Tumors did not grow when inducing IFN-gamma immediately after tumor cell inoculation, while approximately half of the tumors were rejected when IFN-gamma was induced in early established tumors within 2 weeks. Induction of IFN-gamma 2-3 weeks after tumor cell inoculation was less efficient (0-17% rejection). IFN-gamma induction in established tumors led to a reduction of CD146(+) endothelial cells and massive necrosis. Together, we show that vascularized tumors can be rejected by local IFN-gamma expression, but that rejection of established tumors was less efficient over time. This suggests that transplanted tumors became less susceptible to local IFN-gamma treatment the better they are established.
引用
收藏
页码:371 / 378
页数:8
相关论文
共 28 条
  • [1] IFN-γ- and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancers
    Bin Zhang
    Karrison, Theodore
    Rowley, Donald A.
    Schreiber, Hans
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (04) : 1398 - 1404
  • [2] The role of tumor stroma in the interaction between tumor and immune system
    Blankenstein, T
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2005, 17 (02) : 180 - 186
  • [3] Solid tumors "melt" from the inside after successful CD8 T cell attack
    Blohm, U
    Potthoff, D
    van der Kogel, AJ
    Pircher, A
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2006, 36 (02) : 468 - 477
  • [4] A PHASE-I CLINICAL-TRIAL OF RECOMBINANT-DNA GAMMA-INTERFERON
    BROWN, TD
    KOELLER, J
    BEOUGHER, K
    GOLANDO, J
    BONNEM, EM
    SPIEGEL, RJ
    VONHOFF, DD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (05) : 790 - 798
  • [5] ENHANCED IN-VIVO GROWTH AND RESISTANCE TO REJECTION OF TUMOR-CELLS EXPRESSING DOMINANT-NEGATIVE IFN-GAMMA RECEPTORS
    DIGHE, AS
    RICHARDS, E
    OLD, LJ
    SCHREIBER, RD
    [J]. IMMUNITY, 1994, 1 (06) : 447 - 456
  • [6] Characterizing the protective component of the αβ T cell response to transplantable squamous cell carcinoma
    Girardi, M
    Oppenheim, D
    Glusac, EJ
    Filler, R
    Balmain, A
    Tigelaar, RE
    Hayday, AC
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) : 699 - 706
  • [7] Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma
    Gleave, ME
    Elhilali, M
    Fradet, Y
    Davis, I
    Venner, P
    Saad, F
    Klotz, LH
    Moore, MJ
    Paton, V
    Bajamonde, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (18) : 1265 - 1271
  • [8] HENGST JCD, 1980, CANCER RES, V40, P2135
  • [9] MECHANISMS OF REJECTION INDUCED BY TUMOR CELL-TARGETED GENE-TRANSFER OF INTERLEUKIN-2, INTERLEUKIN-4, INTERLEUKIN-7, TUMOR-NECROSIS-FACTOR, OR INTERFERON-GAMMA
    HOCK, H
    DORSCH, M
    KUNZENDORF, U
    QIN, ZH
    DIAMANTSTEIN, T
    BLANKENSTEIN, T
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (07) : 2774 - 2778
  • [10] The rate of the CD8-dependent initial reduction in tumor volume is not limited by contact-dependent perforin, Fas ligand, or TNF-mediated cytolysis
    Hollenbaugh, JA
    Reome, J
    Dobrzanski, M
    Dutton, RW
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 173 (03) : 1738 - 1743